UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Chest, 2021-01, Vol.159 (1), p.337-346

2021

Volltextzugriff (PDF)

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

The European respiratory journal, 2020-08, Vol.56 (2), p.2000008

2020

Volltextzugriff (PDF)

3D printing for preoperative planning and intraoperative surgical jigs - A prospective study on surgeon perception

Journal of Orthopaedic Reports, 2024-09, Vol.3 (3), p.100305, Article 100305

2024

Volltextzugriff (PDF)

Firms' heterogeneity, demand accumulating, and exchange rate pass-through

Southern economic journal, 2020-10, Vol.87 (2), p.700-731

2020

Volltextzugriff (PDF)

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

The Journal of heart and lung transplantation, 2018-06, Vol.37 (6), p.696-705

2018

Volltextzugriff (PDF)

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study

The lancet oncology, 2013-11, Vol.14 (12), p.1216-1225

2013

Volltextzugriff (PDF)

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4060-4066

2013

Volltextzugriff (PDF)

Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-10

2020

Volltextzugriff (PDF)

Pulmonary Arterial Hypertension—Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting

Pulmonary circulation, 2020-04, Vol.10 (2), p.1-9

2020

Volltextzugriff (PDF)

Role of patient specific 3D printed models in patient confidence, understanding and satisfaction of care in Singapore

Journal of orthopaedics, 2024-06, Vol.52, p.28-32

2024

Volltextzugriff (PDF)

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.321-330

2020

Volltextzugriff (PDF)

The Addition of a Non-Steroidal Anti-Inflammatory Drug (NSAID) in Local Infiltration Analgesia During Total Knee Arthroplasty Increases the Risk of Acute Kidney Injury in Patients Who Have Renal Impairment: A Propensity-Matched Retrospective Cohort Study

The Journal of arthroplasty, 2024-10

2024

Volltextzugriff (PDF)

Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials and Observational Registries

Arthritis & rheumatology (Hoboken, N.J.), 2021-05, Vol.73 (5), p.837-847

2021

Volltextzugriff (PDF)

Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension

Chest, 2023-05, Vol.163 (5), p.1232-1244

2023

Volltextzugriff (PDF)

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes

The Journal of heart and lung transplantation, 2023-03, Vol.42 (3), p.377-389

2023

Volltextzugriff (PDF)

CLINICAL CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND TREATMENT PATTERNS: A REAL-WORLD ANALYSIS FROM SPHERE (SELEXIPAG: THE USERS DRUG REGISTRY)

Chest, 2021-10, Vol.160 (4), p.A2292-A2295

2021

Volltextzugriff (PDF)

REAL-WORLD DATA FOR SELEXIPAG IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: A SPHERE (SELEXIPAG: THE USERS DRUG REGISTRY) ANALYSIS

Chest, 2020-10, Vol.158 (4), p.A2187-A2190

2020

Volltextzugriff (PDF)

REVEAL LITE 2 RISK ASSESSMENT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION FROM THE GRIPHON STUDY: A POST-HOC ANALYSIS DEMONSTRATES ASSOCIATION OF RISK STATUS WITH LONG-TERM OUTCOMES

Chest, 2021-10, Vol.160 (4), p.A2318-A2321

2021

Volltextzugriff (PDF)

DEVELOPMENT OF A SIMPLIFIED RISK CALCULATOR FOR STRATIFYING PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION BASED ON ECHOCARDIOGRAPHIC PARAMETERS IN THE REVEAL DATABASE

Chest, 2021-10, Vol.160 (4), p.A2273-A2274

2021

Volltextzugriff (PDF)

MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL

Chest, 2021-10, Vol.160 (4), p.A2284-A2286

2021

Volltextzugriff (PDF)

LONG-TERM CLINICAL COURSE OF THE FIRST 250 PATIENTS TREATED WITH SELEXIPAG IN REAL-WORLD SETTINGS FROM THE SPHERE REGISTRY (SELEXIPAG:THE USERS DRUG REGISTRY)

Chest, 2019-10, Vol.156 (4), p.A866-A869

2019

Volltextzugriff (PDF)

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

Chest, 2018-07, Vol.154 (1), p.126-135

2018

Volltextzugriff (PDF)

APPLICATION OF A BAYESIAN NETWORK MODEL TO PREDICT OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION

Chest, 2018-10, Vol.154 (4), p.1061A-1061A

2018

Volltextzugriff (PDF)

RISK ASSESSMENT IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): APPLICATION OF THE REVEAL 2.0 RISK CALCULATOR

Chest, 2019-10, Vol.156 (4), p.A169-A171

2019

Volltextzugriff (PDF)

1 – 25 von 765

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(674)
Mit Volltextzugriff
(662)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(511)
Life Sciences & Biomedicine
(391)
Humans
(273)
Female
(175)
Male
(162)
Adult
(87)
Middle Aged
(86)
Animals
(85)
Technology
(82)
Biological And Medical Sciences
(76)
Medical Sciences
(59)
Aged
(57)
Child
(50)
Mice
(48)
Science & Technology - Other Topics
(47)
Physical Sciences
(45)
Risk Factors
(41)
Biochemistry & Molecular Biology
(40)
Multidisciplinary Sciences
(40)
Adolescent
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

Risk stratification in pulmonary arterial hypertension using Bayesian analysis

3D printing for preoperative planning and intraoperative surgical jigs - A prospective study on surgeon perception

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial

Firms' heterogeneity, demand accumulating, and exchange rate pass-through

Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis

Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study

Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer

Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries

Pulmonary Arterial Hypertension—Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting

Role of patient specific 3D printed models in patient confidence, understanding and satisfaction of care in Singapore

Impact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry

The Addition of a Non-Steroidal Anti-Inflammatory Drug (NSAID) in Local Infiltration Analgesia During Total Knee Arthroplasty Increases the Risk of Acute Kidney Injury in Patients Who Have Renal Impairment: A Propensity-Matched Retrospective Cohort Study

Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials and Observational Registries

Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension

Smoking history and pulmonary arterial hypertension: Demographics, onset, and outcomes

CLINICAL CHARACTERISTICS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION AND TREATMENT PATTERNS: A REAL-WORLD ANALYSIS FROM SPHERE (SELEXIPAG: THE USERS DRUG REGISTRY)

REAL-WORLD DATA FOR SELEXIPAG IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: A SPHERE (SELEXIPAG: THE USERS DRUG REGISTRY) ANALYSIS

REVEAL LITE 2 RISK ASSESSMENT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION FROM THE GRIPHON STUDY: A POST-HOC ANALYSIS DEMONSTRATES ASSOCIATION OF RISK STATUS WITH LONG-TERM OUTCOMES

DEVELOPMENT OF A SIMPLIFIED RISK CALCULATOR FOR STRATIFYING PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION BASED ON ECHOCARDIOGRAPHIC PARAMETERS IN THE REVEAL DATABASE

MACITENTAN TREATMENT EFFECT IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION TAKING SPIRONOLACTONE: POST-HOC ANALYSIS OF THE PHASE 3 SERAPHIN TRIAL

LONG-TERM CLINICAL COURSE OF THE FIRST 250 PATIENTS TREATED WITH SELEXIPAG IN REAL-WORLD SETTINGS FROM THE SPHERE REGISTRY (SELEXIPAG:THE USERS DRUG REGISTRY)

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry

APPLICATION OF A BAYESIAN NETWORK MODEL TO PREDICT OUTCOMES IN PULMONARY ARTERIAL HYPERTENSION

RISK ASSESSMENT IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): APPLICATION OF THE REVEAL 2.0 RISK CALCULATOR

Suchergebnisse filtern